SANUWAVE Health, Inc. (SNWV)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$4.38-1.57%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · SNWV
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -36.1% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 33.1% |
Growth built into the price is above our model estimate.
The price assumes 69.2 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 88 industry peers · Company calendar date is not available
SNWV — earnings miss
Dated 2026-08-06
Results of Operations and Financial Condition. On August 6, 2026 , Sanuwave H ealth, Inc., a Nevada corporation (the “Company”), issued a press release announcing its financial results for the second quarter ended June 30, 2026. As previously announced, a business update via conference call will occur on August 7, 2026 at 8:30 am EST. Materials are provided on the Company’s website at www.sanuwave.com/investors. The information in this
Why it matters: If health care revenue growth speeds up, it could benefit SANUWAVE's outlook.
Supportive ifHealth care revenue growth is speeding up again. It is moving back toward 10% or more.
Worry ifHealth care revenue growth continues to decelerate below 5%.
Why it matters: The final rule will change reimbursement rates for treatments. These changes could affect sales and profits.
Watch forThe CMS final rule increases payment rates for treatment under code 97610.
Also watch forCMS final rule lowers reimbursement rates or keeps them the same.
Why it matters: An updated revenue guidance will show how the company adapts to reimbursement changes. This is key for investor confidence.
Watch forManagement shares new revenue goals for FY 2026. This comes after CMS shares its final rule.
Also watch forManagement does not give revenue guidance. This shows uncertainty in the market.
Why it matters: Management stopped giving guidance because of market conditions. New guidance will show if things are getting better or worse.
Watch forManagement gives new revenue guidance for Q3 2026. It is above $9.5 million.
Also watch forNo new guidance or guidance remains below $8.5 million.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$220 on $10,000 · ±2.2% | How much price usually moves either way. |
| Bad day | $722 loss on $10,000 · 7.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,927 loss on $10,000 · 89.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Fixing this issue could help Sanuwave's finances. It is a risk that needs watching.
Watch forManagement shares a clear plan to fix the tax issue.
Also watch forNo updates or progress on the tax issue.
Why it matters: Meeting this guidance is important. It helps build investor confidence and shows growth.
Supportive ifFull year 2026 revenue reported within the range of $51 million to $55 million.
Worry ifFull year 2026 revenue reported below $51 million.
Why it matters: Strong growth in applicator revenue shows demand for Ultramist systems. This is key for the company's business model.
Supportive ifApplicator revenue growth exceeds 10% year over year in Q3 2026.
Worry ifApplicator revenue growth is below 5% year over year in Q3 2026.
Why it matters: Better adjusted EBITDA shows the company can manage costs. This helps profits despite revenue issues.
Supportive ifAdjusted EBITDA for Q2 2026 is up from $1.2 million.
Worry ifAdjusted EBITDA falls further from the current $1.2 million.
Why it matters: Missing earnings often means there are bigger problems. These problems can be in making money or management.
Worry ifAnother earnings miss reported in the next quarter.
Less concerning ifEarnings meet or exceed expectations in the next quarter.
Why it matters: The earnings report will provide insights into Sanuwave's financial health and performance. It is a key event for investors.
Watch forEarnings report shows positive trends in revenue and sales.
Also watch forEarnings report shows more declines or bad trends.
Why it matters: Another earnings miss could show ongoing problems. This might hurt how investors feel.
Worry ifQ2 2026 earnings were below what analysts expected.
Less concerning ifQ2 2026 earnings met or beat what analysts expected.
Why it matters: Sales recovery shows if demand is stabilizing after recent issues. It is key for revenue growth.
Supportive ifUltramist system sales rise quarter over quarter from Q2 2026.
Worry ifUltramist system sales continue to decline or remain flat.